Skip to main content

Table 1 Patient demographics and perioperative outcomes

From: Is extended resection for locally advanced thoracic cancer with cardiopulmonary bypass justified?

Patient (intention of surgery)

Pathology

 

Agea

Sex

ECOG

ASA

Lung resection

CVS resection

OP

Timeb (min)

Blood lossc (mL)

ICU dayd

Hospital daye

1# (elective)

Pulmonary blastoma

 

7

F

1

4

Pneumonectomy

SVC

360

200

3

9

2# (salvage)

Mediastinal sarcoma

 

73

M

3

4

Pneumonectomy

SVC

400

3400

24

24

3# (salvage)

Mediastinal teratoma

 

18

M

2

4

Pneumonectomy

SVC

600

1750

4

27

4# (elective)

Pleomorphic lung cancer

 

73

M

1

4

Lobectomy

LA

450

1000

10

16

5# (salvage)

Large cell neuroendocrine

lung cancer

 

61

M

4

4

Pneumonectomy

SVC, LA

570

3000

12

12

6# (elective)

Mediastinal large cell neuroendocrine cancer

 

37

M

0

2

Bilobectomy

SVC, LBV

480

1850

3

12

7# (elective)

Thymic carcinoma

 

49

M

1

3

Wedge resection

LBV, MPA, Aorta

650

700

7

17

8# (elective)

Thymoma

 

53

F

1

3

Nil

SVC, RA, Aorta

660

650

18

34

  1. ECOG: Eastern Cooperative Oncology Group; ASA: American Society of Anesthesiologists; CVS: cardiovascular structure; OP: operation; ICU: intensive care unit; min: minute; mL: milliliter; F: female; M: male; SVC: superior vena cava; LA: left atrium; LBV: left brachiocephalic vein; MPA: main pulmonary artery; RA: right atrium. Values are expressed as means ± standard deviations (SD)
  2. a Mean ± SD, 46.4 ± 24.3 years
  3. b Mean ± SD, 521 ± 114 min
  4. c Mean ± SD, 1,568 ± 1,153 mL
  5. d Mean ± SD, 10.1 ± 7.6 days
  6. e Mean ± SD, 18.9 ± 8.7 days